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ABSTRACT  The optimal treatment strategy for simultaneous lung cancer and abdominal 
aortic aneurysm remains controversial. This report presents the case of a 76-year-old man with 
lung cancer in addition to an abdominal aortic aneurysm. A chest computed tomography (CT) 
examination showed a mass lesion measuring 38 mm in diameter in S6 of the left lower lobe; the 
mass exhibited features suggestive of lung cancer. Meanwhile, an abdominal CT examination 
showed an abdominal aortic aneurysm measuring 52mm in diameter. Considering the 
progression of the lung tumor, we performed a left lower lobectomy and lymph node dissection, 
and the lung tumor was histologically diagnosed by as an adenocarcinoma, pT3(pm1)N1M0. 
On the 58th day after the first surgery, we performed endovascular stent grafting, and on the 31st 
day after the endovascular surgery, adjuvant chemotherapy with carboplatin plus gemcitabine 
was initiated. During the chemotherapy, there were no remarkable adverse events, and the 
treatment was completed as planned.
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InTroducTIon
   Lung cancer with a simultaneous abdominal aortic 
aneurysm (AAA) is rather rare (about 1% of all 
treated cases of lung cancers)1－3）. The concomitant 
presence of the two diseases makes therapeutic 
decisions critical, especially in terms of the priority 
and timing of the treatments. The cumulative 
surgical risk involved in the treatment of the two 
disease conditions and the overall condition of the 
patients, who are often elderly and with impaired 
functions, frequently necessitate a two-stage 
treatment strategy4）. 
   We report the case of a patient in whom a two-
stage operation was performed for lung cancer and 
AAA, followed by adjuvant chemotherapy for the 
lung cancer.
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cAse reporT
   A 76-year-old man was referred to our institute 
for further investigation of an abnormal opacity 
in the left lower lung field on a plain chest X-ray. 
There was no previous history of malignancy. A 
physical examination revealed no abnormalities. 
The  resu l t s  o f  rou t ine  hemato log ica l  and 
biochemical investigations were all nearly normal. 
A chest computed tomography (CT) examination 
revealed a mass lesion measuring 38mm in 
diameter in the lower lobe of the left lung (Fig. 
1A). An 18F-fluorodeoxyglucose positron emission 
tomography (FDG-PET) examination demonstrated 
accumulation in the lung tumor and in a hilar lymph 
node (Fig. 1B). An abdominal CT examination 
revealed a dilated segment of the infrarenal 
abdominal aorta measuring 52mm in diameter (Fig. 
2). Because the lung tumor was highly suspected 
as a locally advanced lung cancer, we decided to 
perform a two-stage surgical treatment. At first, a 
left lower lobectomy and lymph node dissection 
were performed. Pathologically, the lung tumor 
was diagnosed as an adenocarcinoma, pT3(pm1)
N1M0. The patient developed no remarkable 
Fig. 1. Chest CT showing a mass lesion measuring 38×31mm in the lower lobe of the left lung (A), FDG-PET showing 
accumulation in the lung tumor and a hilar lymph node (B).
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Fig. 2. Abdominal CT showing a dilated segment of the 
infrarenal abdominal aorta measuring 52mm.
Fig. 3. Angiography of the endovascular stent graft showing 
absence of any endoleak.
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complications necessitating any treatments during 
the postoperative period. 
   On the 58 th day after the lung resection, 
endovascular stent grafting using the Excluder 
System (Gore, USA) was performed under general 
anesthesia. The final angiogram of the procedure 
showed the effective sealing of the aneurysmal 
sac, with preserved flow in the abdominal aorta 
(Fig.3). There were no major complications during 
the postoperative period. On the 31st day after 
the endovascular surgery, the patient underwent 
adjuvant chemotherapy with carboplatin (area under 
the curve = 2.5) on day 1 and 15, and gemcitabine 
(1000mg/ m2) on day 1 and 15. The chemotherapy 
was repeated every 28 days for a total of 4 cycles. 
During the chemotherapy, the patient developed no 
remarkable adverse events, and the adjuvant therapy 
was completed as planned. To date, 18 months after 
the lung resection, the patient has no evidence of 
lung cancer recurrence or of endoleak from the 
aortic stents. 
dIscussIon
   The reported incidence of simultaneous lung 
cancer and AAA ranges from 0.8 to 1.3% of all 
treated cases of lung cancer1－3）. The therapeutic 
problems in patients with simultaneous lung cancer 
and AAA are mainly related to the appropriate 
surgical  strategies and the t iming of these 
procedures. Simultaneous treatment is more cost-
effective, but it entails double access to the chest 
and abdomen, which significantly increases the 
invasiveness of the surgery5）.
   In a two-stage treatment, it is important to 
determine which surgery should be carried out 
first. In general, the priority should be given to the 
lung cancer surgery because of the risk of cancer 
progression associated with any treatment delay 
and the potential immunologic suppression caused 
by prior abdominal aortic surgery; on the other 
hand, the danger of rupture of the aneurysm might 
necessitate earlier surgery for the aneurysm. The 
reported frequencies of aneurysmal rupture range 
from 0% to 6% for aneurysms with a diameter of 
<5cm, and 9% and 12.5%, for aneurysms measuring 
6.5cm and 7.5cm in size, respectively6,7）. The 
general condition of the patients, including the 
adequacy of the cardiac, renal, respiratory, and 
central nervous functions, must also be carefully 
evaluated, including an assessment of the American 
Society of Anesthesiology risk, before determining 
the operative indications for the AAA.
   In the present case, we assigned priority to the 
lung cancer surgery than to the surgery for the 
AAA, because the lung cancer was suspected of 
being locally advanced, and the risk of AAA rupture 
appeared to be relatively low. For the treatment of 
the AAA, we chose endovascular stent grafting. 
Endovascular stent grafting has radically modified 
the treatment of AAAs, especially for patients 
with a poor general health and a high anesthesia 
risk. It is much less invasive than open surgery 
in the short term8）. In this case, because of the 
detection of an intrapulmonary metastasis and 
a lymph node metastasis from the lung cancer, 
adjuvant chemotherapy was thought to be necessary. 
Therefore, we chose a less invasive surgical method 
for the treatment of AAA, since the invasiveness 
of the surgery might have had an adverse influence 
on the subsequent chemotherapy. The adjuvant 
chemotherapy was completed as planned in 
terms of both the doses and the number of cycles; 
therefore, our decision on assigning priority to the 
surgical treatment for lung cancer and to perform 
endovascular stent grafting for the AAA was 
considered to be appropriate. 
concLusIon
   In  pat ients  wi th  lung cancer  and AAA, 
careful consideration must be given to whether 
simultaneous treatments or two-stage treatment 
would be more appropriate, and to which disease 
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treatment priority should be assigned.Endovascular 
stent grafting can be the treatment of choice in such 
complicated cases.
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